Posted on behalf of Phillips Law Group on Feb 23, 2010 in Defective Drug
In response to the growing level of concern and number of reports regarding Avandia side effects, the Senate made the decision to formulate and issue a report that analyzed the issue and history of this problematic diabetes medication. Those charged with completing the report reviewed more than 25,000 documents detailing the problems associated with Avandia, and among many conclusions, the following appear to be the most noteworthy:
Every one of these conclusions is a serious indictment of GlaxoSmithKline and the FDA, but unfortunately this report is not legally binding in any manner that could directly lead to action.
Despite the lack of a legally binding characteristic with this Senate report, its conclusions are of the type that many people will notice. Given that Avandia remains on the market, this report is yet further proof and potentially evidence for those who have suffered from Avandia side effects and take the courageous step of enforcing their legal rights.
If you or someone you love has suffered harm as a result of using Avandia, contact a Phoenix personal injury lawyer at Phillips Law Group today to discuss your legal options. There are no upfront fees if we handle your claim and your initial consultation is free of charge. Ph: 1-800-706-3000.
The Phillips Law Group. All rights reserved. All materials contained on the Phillips Law Group website are copyrighted including trademarks, and other proprietary information including the content on its blogs, the home page, and all website pages. The material contained on this website may not be copied, reproduced, modified, transmitted, displayed, or distributed without written permission of the Phillips Law Group. Any reposting, distribution, or displaying of website content on any other business website without prior written consent is a violation of copyright laws. The Phillips Law Group disclaims all liability for content maintained on other websites that are linked to this firm's website.